{"id":"W3196589094","doi":"10.1016/j.clon.2021.08.009","title":"Real-world Safety of Bevacizumab with First-line Combination Chemotherapy in Patients with Metastatic Colorectal Cancer: Population-based Retrospective Cohort Studies in Three Canadian Provinces","year":2021,"lang":"en","type":"review","venue":"Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"ca_institutions":"Canadian Partnership Against Cancer; Ontario Institute for Cancer Research; St. Michael's Hospital; Sunnybrook Health Science Centre; Alberta Cancer Foundation; Institute for Clinical Evaluative Sciences; Simon Fraser University; University of Toronto; Occupational Cancer Research Centre; Saskatchewan Cancer Agency; Canadian Centre for Applied Research in Cancer Control; Cancer Care Ontario","funders":"","keywords":"Bevacizumab; Medicine; Irinotecan; Internal medicine; Odds ratio; Colorectal cancer; Propensity score matching; Confidence interval; Oncology; Retrospective cohort study; Population; Surgery; Chemotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000609511,0.0004527937,0.005405436,0.000442942,0.00008231134,0.000005495992,0.0001126258,0.0002440761,0.00005969037],"category_scores_gemma":[0.0004958469,0.0002884322,0.0002410318,0.001077537,0.0004015144,0.00004438152,0.00003512818,0.0005724297,7.995968e-7],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.009355279,"about_ca_system_score_gemma":0.006822146,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1185128,"about_ca_topic_score_gemma":0.9781131,"domain_scores_codex":[0.9965806,0.0003395982,0.001632529,0.0007200719,0.0003636316,0.0003635886],"domain_scores_gemma":[0.9963356,0.001689234,0.0009929804,0.0002519172,0.0005810616,0.00014919],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002054414,0.001267154,0.8144712,0.001704216,0.002108571,0.0001103455,0.00007604498,0.0000126268,6.94813e-10,0.00004431316,0.00003021405,0.1781209],"study_design_scores_gemma":[0.0114001,0.009736401,0.9562199,0.009458055,0.002152715,0.000002092041,0.00003784873,0.00001490237,9.222736e-8,0.00002794286,0.01069021,0.0002598012],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2822183,0.706967,0.000001531671,0.001008976,0.0005050311,0.007985205,0.0003491701,0.00002715335,0.000937604],"genre_scores_gemma":[0.1712511,0.8266191,0.0002538703,0.00008491403,0.00005879474,0.0009856763,0.0006425169,0.00004687757,0.00005710018],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8596002,"threshold_uncertainty_score":0.9999568,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08227610068113814,"score_gpt":0.4400595331113387,"score_spread":0.3577834324302006,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}